Radoslaw Parma

Be a part of EAPCI and apply to become a Committee Member for the 2026-2028 mandate 🧑‍🧑‍🧒‍🧒🫀 🌍 This is your opportunity to actively contribute to our community and collaborate with colleagues across ESC National Societies and Affiliated Countries 📌 Important Details: 👤 Eligibility: You must be an EAPCI Member to apply ⏰ Deadline: 26 July 2026 📢 Results Announcement: September 2026 🔗 Submit your application today: escardio.org/communities/as… Not a member yet? Join Today: escardio.org/membership/eap… 🚀 #EAPCIfamily #EAPCIcommunity #EAPCIcommittees @escardio

At #NYValves2026 🇺🇸 I think of a lesson from my Polish mentors that real progress comes from teamwork, effort, and staying together. Our research and clinical contributions presented here in New York are built on years of work, trust, and collaboration back home in Poland 🇵🇱. I feel privileged to be part of this team and to keep learning from such people. They are precious. @CRFHeart @PCRonline @aisnptk @PTKardio @escardio

Full Heart Team Arena today at today’s joint @CRFheart and @PCRonline late-breaking TAVR session at #NYValves2026. 🔹PARTNER 3, EARLY TAVR, VA-CART Evolut, Evolut durability/reintervention, and low-risk bicuspid Evolut data. An excellent example of 🇺🇸 & 🇪🇺 collaboration! 💎

Excellent best-practice document on redo-TAVR from the Heart & Valve Collaborative, being presented today at #NYValves2026 and now published in JACC Journals. Congratulations to all co-authors for this achievement! Prospective data from #ReTAVI (30 day data published!), #ReValve and #RESTORE will now be key to further refine this space. 💡 @G_Tarantini01 @DanBlackman7 @GuiAttizzaniMD

Proud to have helped curate the 2-part landmark special issue on LEAFLET MODIFICATION (LM) in #JACCINT @JACCJournals with Editor-in-Chief David Moliterno and Vasilis Babaliaros to celebrate the 10-anniversary of the 1st leaflet modification done in the world (LAMPOON)! Grateful to be a senior author and co-author of several papers. jacc.org/toc/interventi… jacc.org/toc/interventi… Congrats to all the authors from around the world who have contributed to this seminal effort! Key highlights: Leaflet modification algorithms: jacc.org/doi/full/10.10… AORTIC Leaflet Modification BASILICA step-by-step review: jacc.org/doi/full/10.10… UNICORN step-by-step review: jacc.org/doi/full/10.10… "Split-line" Concept in LM in Redo-TAVR: jacc.org/doi/full/10.10… UNICORN benchtop validation in redo-TAVR: works better with failed Sapien, Evolut, Acurate than Navitor: jacc.org/doi/full/10.10… UNICORN registry: jacc.org/doi/full/10.10… Bench testing showing UNICORN more effective than (BA)BASILICA in Redo-TAVR: jacc.org/doi/full/10.10… Bench testing showing LM in redo-TAVR dependent on TAV type, constraint, 2nd TAV implant. BASILICA no effect on Navitor and BA-BASILICA better with failed Evolut + Acurate jacc.org/doi/full/10.10… HALT reduction with leaflet modification in VIV #TAVR: jacc.org/doi/full/10.10… Bench testing on LM of calcified native and SAV leaflets showed higher Ca burden increased laceration difficulty, leaflet tears and embolic debris; less spray with shorter leaflet length jacc.org/doi/full/10.10… LOFTER-TAVR registry: jacc.org/doi/full/10.10… CT simulation of LM impact on Redo-TAVR Feasibility: jacc.org/doi/full/10.10… Fluoro Left-Main Frame Alignment View to Evaluate coronary obstruction in redo-TAVR: jacc.org/doi/full/10.10… FIH wire anchoring-assisted BASILICA/UNICORN: jacc.org/doi/full/10.10… FIH tricupsidization of bicuspid native #TAVR jacc.org/doi/full/10.10… Mitral Leaflet Modification LAMPOON/BATMAN step-by-step: jacc.org/doi/full/10.10… BATMAN registry jacc.org/doi/full/10.10… TRICUSPID Leaflet Modification ELASTA-T for failed T-TEER to facilitate TTVR step-by-step: jacc.org/doi/full/10.10… Mechanisms of failed BASILICA/LAMPOON/SEASAME: jacc.org/doi/full/10.10…

@GilbertTangMD @ABeneduceMD This is an exceptional source of knowledge and training for SHD operators. Congratulations to all the authors.

Warm thank you to all attendees and faculty of the #THTImaging TAVI CT Express course in Gdynia. Congratulations to the PKWKI Conference directors on a truly professional event 🇵🇱! @RafalWolny @JoannaNawara @ukasz09659358 #TAVI #CardiacCT #StructuralHeart @aisnptk @PCRonline

The number of redo-TAVI procedures is expected to rise substantially as indications expand to younger patients with aortic stenosis who are likely to outlive their index transcatheter heart valve. The ReTAVI registry represents the first prospective, multicentre evaluation of redo-TAVI providing systematically collected, core lab-adjudicated data on procedural feasibility and early outcomes. eurointervention.pcronline.com/article/early-…

@EuroInterventio @KardiologieHH Congratulations to the Editorial Team and the authors for this achievement! 🇪🇺

EuroIntervention ranks #1 in Interventional Cardiology with a CiteScore of 13.0 We are pleased to share that the journal has achieved outstanding results in the latest Scopus CiteScore 2025 rankings. 📈 CiteScore: 13.0 🥇 #1 in Interventional Cardiology This reflects the scientific quality and impact of the work published in the journal, as well as the commitment of authors, reviewers, and the editorial team. #CiteScore #InterventionalCardiology #Scopus

@hahn_rt @SLittleMD @ASE360 @JournalASEcho @ACCinTouch @SCAI @purviparwani @iamritu A wonderful read for Heart Teams. Thank you and congratulations to all the authors. @EACVIPresident @EAPCIPresident @THTconference @PTKardio @PCRonline

NEW ASE Recommendations for the Intraprocedural Imaging for M-TEER bit.ly/ASE_M-TEER @SLittleMD @ASE360 @JournalASEcho @ACCinTouch @SCAI @purviparwani @iamritu

@EuroInterventio Proud of the entire ReTAVI collaboration. Thank you to all investigators, Heart Teams and participating centres. More insights from the first prospective TAV-in-TAV registry are coming soon! ⭐️ #ReTAVI

Redo-TAVI is becoming an increasingly important component of lifetime management in aortic stenosis. In the prospective multi centre ReTAVI registry, redo-TAVI with the balloon-expandable SAPIEN 3 platform achieved high procedural success (95.1%), low 30-day mortality (3.5%) and stroke (0.7%) rates, with favourable haemodynamic outcomes across different failed THV types. eurointervention.pcronline.com/article/early-… @G_Tarantini01 @naifovino @parma @RafalWolny @tommaso_fabris #TAVI #RedoTAVI #StructuralHeartDisease #CardioTwitter

🎙️This was the afternoon coffee topic at the CSI Frankfurt 2026 Cathlab Cafe ☕️! “We discuss only controversial cases at the Heart Team meeting” 🫀 What is your experience? Do you discuss every patient, or only selected cases? 🔗 fr.surveymonkey.com/r/QWQLYDG #TAVI #HeartTeam #StructuralHeart #CardioTwitter #CSIFrankfurt #ValvularHeartDisease

The best learning? Not the slides. Clear, frank conversations. Outstanding discussions on TAVI, SHD, and AI at #CSIFrankfurt. Not just presenting: challenging ideas and learning from each other. @OKhaliqueMD @LCC_DrMalik @MoFFarag @drnvanmieghem #TAVI #StructuralHeart #AI #Robotics

@GilbertTangMD @KHERA_MD @DoctorKini @DLBHATTMD @MountSinaiHeart A great team!

FIRST #Mirus #Siegel #TAVR in #NewYork in the #STAR pivotal trial! Thank you to my co-PI @KHERA_MD for his leadership, Dr. Samin K. Sharma @DoctorKini @DLBHATTMD Hyo Jin Kang, MSN, AGPCNP-C for their support, and the entire @MountSinaiHeart research team for their efforts, and to our patients for trusting us with this groundbreaking #TAVR technology. @MountSinaiNYC @IcahnMountSinai @Dr_BrendanCarr @DrDavidReich @BethOliverVP @Drroxmehran

CT for TAVI is no longer only about annulus sizing. It is lifetime planning. 🫀 Join our hands-on THT Imaging workshop with 3mensio training: 🔹 Coronary re-access 🔹 Commissural alignment 🔹 TAV-in-TAV feasibility 🔹 CT surveillance 📅 13 Jun 2026, Warsaw, Akademia Siemens Healthineers 🔗 thtimaging.com/tht/computed-t… #TAVI #CTforTAVI #HeartTeam @RafalWolny @JoannaNawara @aisnptk @PCRonline